BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0), a plant-based compounds company, will participate in the 38th Annual Roth Conference in Dana Point, California from 22 to 24 March, with chief executive Ilan Sobel hosting one-on-one meetings with institutional investors throughout the event.
Sobel said the company was at an important inflection point following a successful fourth-quarter 2025 financing round, with more than 85,000 direct consumer customers and anchor contract development and manufacturing partnerships in place heading into 2026.